These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 39048130)

  • 1. Exacerbations of bronchiectasis.
    De Angelis A; Johnson ED; Sutharsan S; Aliberti S
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 39048130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.
    Brill SE; Patel AR; Singh R; Mackay AJ; Brown JS; Hurst JR
    Respir Res; 2015 Feb; 16(1):16. PubMed ID: 25849856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.
    Chalmers JD; Sethi S
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):18. PubMed ID: 28270656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development of bronchiectasis in patients with asthma.
    Ma D; Cruz MJ; Ojanguren I; Romero-Mesones C; Varona-Porres D; Munoz X
    Sci Rep; 2021 Nov; 11(1):22820. PubMed ID: 34819607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growing from common ground: nontuberculous mycobacteria and bronchiectasis.
    Van Braeckel E; Bosteels C
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in bronchiectasis.
    Johnson E; Long MB; Chalmers JD
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.
    Ni Y; Shi G; Yu Y; Hao J; Chen T; Song H
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1465-75. PubMed ID: 26251586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.
    Chalmers JD; Moffitt KL; Suarez-Cuartin G; Sibila O; Finch S; Furrie E; Dicker A; Wrobel K; Elborn JS; Walker B; Martin SL; Marshall SE; Huang JT; Fardon TC
    Am J Respir Crit Care Med; 2017 May; 195(10):1384-1393. PubMed ID: 27911604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.
    Martinez-Garcia MA; Athanazio RA; Girón R; Máiz-Carro L; de la Rosa D; Olveira C; de Gracia J; Vendrell M; Prados-Sánchez C; Gramblicka G; Corso Pereira M; Lundgren FL; Fernandes De Figueiredo M; Arancibia F; Rached SZ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():275-284. PubMed ID: 28182132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital.
    Altenburg J; Wortel K; van der Werf TS; Boersma WG
    Neth J Med; 2015 May; 73(4):147-54. PubMed ID: 25968285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention.
    Bell SC; Elborn JS; Byrnes CA
    Respirology; 2018 Nov; 23(11):1006-1022. PubMed ID: 30207018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment adherence and health outcomes in patients with bronchiectasis.
    McCullough AR; Tunney MM; Quittner AL; Elborn JS; Bradley JM; Hughes CM
    BMC Pulm Med; 2014 Jul; 14():107. PubMed ID: 24980161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiome in bronchiectasis.
    Richardson H; Dicker AJ; Barclay H; Chalmers JD
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31484665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiectasis in COPD patients: more than a comorbidity?
    Martinez-Garcia MA; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1401-1411. PubMed ID: 28546748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V; Bartlett J; Jayaram L
    Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema.
    Mansharamani NG; Koziel H
    Curr Opin Pulm Med; 2003 May; 9(3):181-5. PubMed ID: 12682562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric and adult bronchiectasis: Monitoring, cross-infection, role of multidisciplinary teams and self-management plans.
    Navaratnam V; Forrester DL; Eg KP; Chang AB
    Respirology; 2019 Feb; 24(2):115-126. PubMed ID: 30500093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.